Bilix is Drug Discovery in South Korea that focus on chronic inflammatory business. Founded in 2018. They cover business area such as developer, therapeutic drug, cure, incurable disease, drug development, acute and chronic inflammatory disease, patient, their health.
2018
( 6 years old in 2024 )
Chronic Inflammatory
-
Building C 338 Gwanggyojungang-ro Suji-gu
Suite 604
Yongin, 16942
South Korea
Private
developertherapeutic drugcureincurable diseasedrug developmentacute and chronic inflammatory diseasepatienttheir health
* We use standard office opening hours in near Bilix's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bilix is Drug Discovery business from South Korea that founded in 2018 (6 years old in 2024), Bilix business is focusing on Chronic Inflammatory.
Bilix headquarter office and corporate office address is located in Building C 338 Gwanggyojungang-ro Suji-gu Suite 604 Yongin, 16942 South Korea.
Bilix was founded in South Korea.
In 2024, Bilix is currently focus on chronic inflammatory sector.
Above is snippet of Google Trends for "chronic inflammatory" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bilix, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
